Amanote Research

Amanote Research

    RegisterSign In

Can a Cyclooxygenase Inhibitor Be an Option for Treatment of Ovarian Hyperstimulation Syndrome?

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s188583
Full Text
Open PDF
Abstract

Available in full text

Categories
Drug DiscoveryPharmacologyPharmaceutical Science
Date

April 1, 2019

Authors
Hasan Çilgın
Publisher

Informa UK Limited


Related search

Ovarian Hyperstimulation Syndrome

BMJ
2009English

Prevention and Treatment of Moderate and Severe Ovarian Hyperstimulation Syndrome: A Guideline

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2016English

Secondary Predictors of Ovarian Hyperstimulation Syndrome Development

Zaporozhye Medical Journal
2019English

Ovarian Hyperstimulation Syndrome in Spontaneous Pregnancy

Journal of Gynecological Research and Obstetrics
2016English

Prevention and Management of Ovarian Hyperstimulation Syndrome

Thrombosis Research
Hematology
2017English

Risk of Ovarian Torsion in Patients With Ovarian Hyperstimulation Syndrome

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2019English

Preterm Ovarian Hyperstimulation Syndrome: A Clinical Presentation of Three Cases

Journal of Gynecology and Neonatal Biology
2018English

Varicose Veins: Surgery Can Still Be Considered as an Option in the Treatment

IOSR Journal of Dental and Medical Sciences
2014English

A Early Development of Severe Ovarian Hyperstimulation Syndrome Following Ovulation Induction

JMS SKIMS
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy